menhycia (cansino biologics inc
menhycia (cansino biologics inc: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Lead developer: Sanofi (SNY)
Development Pipeline (1)
| Company | Phase |
|---|---|
| Sanofi (SNY) | Phase 3 |
Clinical Trials (1)
A Phase 3, Modified-double Blind, Multi-center Study of the Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Infants and Toddlers (2 to 23 Months of Age) in China
Frequently asked questions
Who is developing menhycia (cansino biologics inc?
menhycia (cansino biologics inc is being developed by Sanofi.
How many clinical trials involve menhycia (cansino biologics inc?
BioSniper tracks 1 clinical trial involving menhycia (cansino biologics inc.
Analyze Sanofi & menhycia (cansino biologics inc with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company